Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
9,76 USD | -0,41% |
|
+13,49% | -42,76% |
Attività
Numero di dipendenti: 120
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Carol Suh
FOU | Founder | 33 | 01/11/19 |
Henry Gosebruch
CEO | Chief Executive Officer | 51 | 18/07/23 |
Paul Berns
FOU | Founder | 57 | 01/11/19 |
Joshua Pinto
DFI | Director of Finance/CFO | 38 | 01/06/21 |
Raj Manchanda
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/07/23 |
Nicholas Brandon
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/04/20 |
Robert Lenz
CTO | Chief Tech/Sci/R&D Officer | - | 10/10/23 |
Corporate Officer/Principal | 48 | 01/08/21 | |
Amy Sullivan
HRO | Human Resources Officer | - | 01/01/21 |
Lori Houle
PRN | Corporate Officer/Principal | 57 | 01/04/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Paul Berns
FOU | Founder | 57 | 01/11/19 |
May Kin Ho
BRD | Director/Board Member | 71 | 01/04/21 |
Kristina Burow
BRD | Director/Board Member | 50 | 01/01/20 |
Matthew Fust
BRD | Director/Board Member | 59 | 01/12/20 |
Henry Gosebruch
CEO | Chief Executive Officer | 51 | 18/07/23 |
Alaa Halawa
BRD | Director/Board Member | 42 | 01/09/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 159 523 997 | 114 631 990 ( 71,86 %) | 0 | 71,86 % |
Coordinate società
![Indirizzo Neumora Therapeutics, Inc.(NMRA)](https://cdn.zonebourse.com/static/address/159308146.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-42,76% | 1,56 Mrd | |
+16,59% | 44,44 Mrd | |
+41,02% | 39,84 Mrd | |
-10,62% | 37,68 Mrd | |
+29,92% | 31,46 Mrd | |
-9,23% | 27,02 Mrd | |
+12,34% | 26,29 Mrd | |
+41,53% | 13,8 Mrd | |
+31,49% | 12,46 Mrd | |
-7,40% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione NMRA
- Società Neumora Therapeutics, Inc.